Regional
Ascension Saint Joseph Hospital EMS System
Ascension Saint Joseph Hospital EMS System (Elgin, IL) carries 30 drugs across 127 dose entries in its current published protocol, effective 2023-01-01.
The current listed document is more than 24 months old and may be outdated.
Drugs and doses30
Acetaminophen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 1000 mg | IV | not captured | standing | page 9 |
| Mild to moderate pain | adult | 625–1000 mg | PO | not captured | standing | page 9 |
| Mild to moderate pain | peds | 10–15 mg/kg | PO | not captured | standing | page 9 |
| Mild to moderate pain | peds | 15 mg/kg | IV | not captured | standing | page 9 |
Adenosine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Narrow-complex tachycardia | adult | 6 mg | IV | not captured | standing | page 22 |
| Narrow-complex tachycardia | peds | 0.1 mg/kg (max 6 mg) | IV | not captured | standing | page 22 |
| Wide-complex tachycardia | adult | 6 mg | IV | not captured | standing | page 23 |
Albuterol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 2.5 mg | NEB | not captured | standing | page 16 |
| Asthma / bronchospasm | peds | 2.5 mg | NEB | not captured | standing | page 16 |
| Hyperkalemia | adult | 5–20 mg | NEB | not captured | standing | page 28 |
| Hyperkalemia | peds | 5–20 mg | NEB | not captured | standing | page 28 |
Aspirin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 324 mg | PO | not captured | standing | page 20 |
Calcium Gluconate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Burns | adult | 2.5% gel | TOP | not captured | standing | page 52 |
| Burns | peds | 2.5% gel | TOP | not captured | standing | page 52 |
Dextrose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 12.5–25 g | not captured | not captured | standing | page 37 |
| Hypoglycemia | peds | 0.5 g/kg | not captured | not captured | standing | page 37 |
Diazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Seizure | adult | 2 mg | IV/IO | not captured | standing | page 9 |
| Seizure | adult | 4–20 mg | not captured | not captured | standing | page 9 |
| Seizure | peds | 0.3 mg/kg | IV/IO | not captured | standing | page 9 |
| Seizure | peds | 0.5 mg/kg | not captured | not captured | standing | page 9 |
Diphenhydramine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 1 mg/kg | PO | not captured | standing | page 16 |
| Allergic reaction | adult | 1 mg/kg | IM | not captured | standing | page 16 |
| Allergic reaction | adult | 1 mg/kg | IV | not captured | standing | page 16 |
| Allergic reaction | adult | 50 mg | IV | not captured | standing | page 16 |
| Allergic reaction | adult | 50 mg | IM | not captured | standing | page 16 |
| Allergic reaction | adult | 50 mg | PO | not captured | standing | page 16 |
| Allergic reaction | peds | 1 mg/kg | PO | not captured | standing | page 16 |
| Allergic reaction | peds | 1 mg/kg | IM | not captured | standing | page 16 |
| Allergic reaction | peds | 1 mg/kg | IV | not captured | standing | page 16 |
| Allergic reaction | peds | 1 mg/kg | IV | not captured | standing | page 16 |
| Allergic reaction | peds | 1 mg/kg | IM | not captured | standing | page 16 |
| Allergic reaction | peds | 1 mg/kg | PO | not captured | standing | page 16 |
| Anaphylaxis | adult | 50 mg | IV/IO | not captured | standing | page 16 |
| Anaphylaxis | adult | 50 mg | IM | not captured | standing | page 16 |
| Anaphylaxis | peds | 1 mg/kg | IV/IO | not captured | standing | page 16 |
| Anaphylaxis | peds | 1 mg/kg | IM | not captured | standing | page 16 |
| Dystonic reaction | adult | 50 mg | IM | not captured | standing | page 102 |
| Dystonic reaction | peds | 1 mg/kg | IM | not captured | standing | page 102 |
Dopamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 2–20 mcg/kg | IV/IO | not captured | standing | page 102 |
| Bradycardia | adult | 2–20 mcg/kg | IV/IO | not captured | standing | page 102 |
| Cardiogenic shock | adult | 2–20 mcg/kg | IV/IO | not captured | standing | page 102 |
| Hypotension / shock | adult | 2–20 mcg/kg | IV/IO | not captured | standing | page 102 |
| Sepsis | adult | 2–20 mcg/kg | IV/IO | not captured | standing | page 102 |
Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 0.1 mg | IV/IO | not captured | standing | page 16 |
| Anaphylaxis | adult | 0.3 mg | IM | not captured | standing | page 16 |
| Anaphylaxis | peds | < 25 kg: 0.15 mg; ≥ 25 kg: 0.3 mg | IM | not captured | standing | page 16 |
| Anaphylaxis | peds | 0.01 mg/kg | IV/IO | not captured | standing | page 16 |
| Asthma / bronchospasm | adult | 0.3 mg | IM | not captured | standing | page 17 |
| Asthma / bronchospasm | peds | < 25 kg: 0.15 mg; ≥ 25 kg: 0.3 mg | IM | not captured | standing | page 17 |
| Bradycardia | peds | 0.01 mg/kg | IV/IO | not captured | standing | page 86 |
| Cardiac arrest | adult | 1 mg | IV/IO | not captured | standing | page 25 |
| Cardiac arrest | peds | 0.01 mg/kg | IV/IO | not captured | standing | page 25 |
| Croup | adult | 0.5 mg | NEB | not captured | standing | page 85 |
| Hypotension / shock | adult | 5–10 mcg | IV/IO | not captured | standing | page 9 |
Fentanyl
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Severe pain | adult | 1 mcg/kg (max 100 mcg) | IV/IO/IM/IN | not captured | standing | page 9 |
| Severe pain | peds | 1 mcg/kg (max 100 mcg) | IV/IO/IM/IN | not captured | standing | page 9 |
Glucagon
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 1 mg | IV/IO | not captured | standing | page 16 |
| Anaphylaxis | adult | 1 mg | IM/IN | not captured | standing | page 16 |
| Bradycardia | adult | 1 mg | IV/IO | not captured | standing | page 21 |
| Bradycardia | adult | 1 mg | IM/IN | not captured | standing | page 21 |
| Bradycardia | peds | 0.5 mg | IV/IO | not captured | standing | page 21 |
| Bradycardia | peds | 0.5 mg | IM/IN | not captured | standing | page 21 |
| Hypoglycemia | adult | 1 mg | IM | not captured | standing | page 16 |
| Hypoglycemia | adult | 1 mg | IN | not captured | standing | page 37 |
| Hypoglycemia | peds | 0.5 mg | IM | not captured | standing | page 16 |
| Hypoglycemia | peds | 0.5 mg | IN | not captured | standing | page 37 |
Hydroxocobalamin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cyanide poisoning | adult | 5 g | not captured | not captured | standing | page 33 |
| Cyanide poisoning | peds | 70 mg/kg | not captured | not captured | standing | page 33 |
Ipratropium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 0.5 mg | not captured | not captured | standing | page 16 |
| Asthma / bronchospasm | peds | 0.25–0.5 mg | not captured | not captured | standing | page 16 |
Ketamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Severe pain | adult | 0.25–0.3 mg/kg (max 50 mg) | IV | not captured | standing | page 9 |
| Severe pain | adult | 0.25–0.3 mg/kg (max 50 mg) | IM/IN | not captured | standing | page 9 |
| Severe pain | peds | 0.25–0.3 mg/kg (max 50 mg) | IV | not captured | standing | page 9 |
| Severe pain | peds | 0.25–0.3 mg/kg (max 50 mg) | IM/IN | not captured | standing | page 9 |
| Procedural sedation | adult | 2 mg/kg | IV | not captured | standing | page 15 |
| Procedural sedation | peds | 2 mg/kg | IV | not captured | standing | page 15 |
Ketorolac
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 15 mg | IV | not captured | standing | page 9 |
| Mild to moderate pain | adult | 30 mg | IM | not captured | standing | page 9 |
| Mild to moderate pain | peds | 0.5 mg/kg | IV | not captured | standing | page 9 |
| Mild to moderate pain | peds | 1 mg/kg | IM | not captured | standing | page 9 |
Lidocaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1 mg/kg | IO | not captured | standing | page 8 |
| Other | peds | 0.5 mg/kg | IO | not captured | standing | page 8 |
Magnesium Sulfate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 2 g | IV/IO | not captured | standing | page 17 |
| Asthma / bronchospasm | peds | 25 mg/kg | IV/IO | not captured | standing | page 17 |
| Eclampsia / pre-eclampsia | adult | 2 g | IV/IO | not captured | standing | page 74 |
| Eclampsia / pre-eclampsia | adult | 2 g | IV/IO | not captured | standing | page 74 |
| VF / pulseless VT | adult | 2 g | IV/IO | not captured | standing | page 23 |
| VF / pulseless VT | peds | 25 mg/kg | IV/IO | not captured | standing | page 23 |
Midazolam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Procedural sedation | adult | 2–5 mg | IV/IN | not captured | standing | page 22 |
| Procedural sedation | peds | 0.1 mg/kg | IV/IN | not captured | standing | page 22 |
| Seizure | adult | 2 mg | IV/IO | not captured | standing | page 29 |
| Seizure | adult | 2 mg | IM/IN | not captured | standing | page 29 |
| Seizure | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 29 |
| Seizure | peds | 0.2 mg/kg | IM/IN | not captured | standing | page 29 |
Naloxone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Opioid overdose | adult | 1 mg | IV/IO | not captured | standing | page 25 |
| Opioid overdose | adult | 1 mg | IM/IN | not captured | standing | page 25 |
| Opioid overdose | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 25 |
| Opioid overdose | peds | 0.1 mg/kg | IM/IN | not captured | standing | page 25 |
Nerve Agent Antidote Kit
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nerve agent exposure | adult | 1 dose (Mark I or DuoDote) | IM | not captured | standing | page 63 |
Nitroglycerin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 0.4 mg | SL | not captured | standing | page 20 |
| CHF / pulmonary edema | adult | 0.4 mg | SL | not captured | standing | page 26 |
| Other | adult | 0.4 mg | SL | not captured | standing | page 38 |
Nitrous Oxide
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 50% nitrous oxide and 50% oxygen | NEB | not captured | standing | page 9 |
| Mild to moderate pain | peds | 50% nitrous oxide and 50% oxygen | NEB | not captured | standing | page 9 |
Norepinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypotension / shock | peds | 0.1 mcg/kg | IV/IO | not captured | standing | page 9 |
Ondansetron
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 4 mg | ODT | not captured | standing | page 8 |
| Nausea / vomiting | adult | 4 mg | IV | not captured | standing | page 8 |
| Nausea / vomiting | peds | 0.15 mg/kg (max 4 mg) | ODT | not captured | standing | page 8 |
| Nausea / vomiting | peds | 0.15 mg/kg (max 4 mg) | IV | not captured | standing | page 8 |
Oral Glucose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 15 g | PO | not captured | standing | page 37 |
| Hypoglycemia | peds | 0.3 g/kg | PO | not captured | standing | page 37 |
Sodium Bicarbonate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | 1 mEq/kg | IV/IO | not captured | standing | page 25 |
| Cardiac arrest | peds | 1 mEq/kg | IV/IO | not captured | standing | page 25 |
| Crush injury | adult | 50 mEq | IV/IO | not captured | standing | page 57 |
| Crush injury | peds | 50 mEq | IV/IO | not captured | standing | page 57 |
| Hyperkalemia | adult | 50 mEq | IV/IO | not captured | standing | page 28 |
| Hyperkalemia | peds | 50 mEq | IV/IO | not captured | standing | page 28 |
| Tricyclic overdose | adult | 1 mEq/kg | IV/IO | not captured | standing | page 31 |
| Tricyclic overdose | peds | 1 mEq/kg | IV/IO | not captured | standing | page 31 |
Tetracaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1 gtt | not captured | not captured | standing | page 54 |
| Other | peds | 1 gtt | not captured | not captured | standing | page 54 |
| Mild to moderate pain | adult | 1 gtt | not captured | not captured | standing | page 54 |
| Mild to moderate pain | peds | 1 gtt | not captured | not captured | standing | page 54 |
Tranexamic Acid
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Obstetric hemorrhage | adult | 1 g | not captured | not captured | standing | page 28 |
| Trauma / hemorrhage | adult | 1 g | not captured | not captured | standing | page 28 |
| Trauma / hemorrhage | adult | 1 g | not captured | not captured | standing | page 46 |
Verapamil
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Narrow-complex tachycardia | adult | 5 mg | IV | not captured | standing | page 22 |